BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/30/2025 8:58:18 AM | Browse: 180 | Download: 677
 |
Received |
|
2024-11-29 07:57 |
|
Peer-Review Started |
|
2024-11-29 07:58 |
|
First Decision by Editorial Office Director |
|
2025-01-10 09:27 |
|
Return for Revision |
|
2025-01-10 09:27 |
|
Revised |
|
2025-01-24 09:27 |
|
Publication Fee Transferred |
|
2025-02-14 15:24 |
|
Second Decision by Editor |
|
2025-03-17 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-03-17 07:41 |
|
Articles in Press |
|
2025-03-17 07:41 |
|
Edit the Manuscript by Language Editor |
|
2025-03-24 02:19 |
|
Typeset the Manuscript |
|
2025-04-15 07:19 |
|
Publish the Manuscript Online |
|
2025-04-30 08:58 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Prospective Study |
| Article Title |
Effectiveness and safety of blonanserin monotherapy in first-episode schizophrenia with and without prominent negative symptoms: A prospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-He Chen, Qian Guo, Yao Hu, Xiao-Hua Liu, Hao Hu, Hai-Ying Chen, Cai-Ping Liu, Hua-Fang Li, Jin-Dong Chen and Guan-Jun Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guan-Jun Li, Chief Physician, PhD, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, No. 600 Wanping Nan Road, Shanghai 200030, China. liguanjun66@126.com |
| Key Words |
Schizophrenia; Blonanserin; Negative symptoms; Effectiveness; Safety; Dose |
| Core Tip |
Blonanserin effectively improved overall and negative symptoms of first-episode schizophrenia with an acceptable safety profile. High-dose blonanserin showed greater efficacy than low-dose for patients with prominent negative symptoms without an increase in adverse drug reactions. Conversely, low-dose blonanserin provided comparable clinical improvement and safety compared to high-dose for patients without prominent negative symptoms. |
| Publish Date |
2025-04-30 08:58 |
| Citation |
Chen LH, Guo Q, Hu Y, Liu XH, Hu H, Chen HY, Liu CP, Li HF, Chen JD, Li GJ. Effectiveness and safety of blonanserin monotherapy in first-episode schizophrenia with and without prominent negative symptoms: A prospective study. World J Psychiatry 2025; 15(5): 103701 |
| URL |
https://www.wjgnet.com/2220-3206/full/v15/i5/103701.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v15.i5.103701 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
